網膜バイオシミラーの世界市場 2020年：企業別・地域別・種類別・用途別市場予測

• 英文タイトル：Global Retinal Biosimilars Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16552 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、網膜バイオシミラーの世界市場を広く調査・分析し、今後の市場展望をまとめております。網膜バイオシミラーの種類別市場規模（黄斑変性症治療薬、糖尿病性眼症治療薬、黄斑斑薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis (Sandoz)、Intas Pharmaceuticals、Genentech、Takeda、Hetero Drugs、Bayer、Regeneron Pharmaceuticals、Reliance Life Sciences、Pfenex、Santo Holding ・地域別グローバル市場分析 2015年-2020年 ・網膜バイオシミラーの北米市場（アメリカ、カナダ、メキシコ） ・網膜バイオシミラーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・網膜バイオシミラーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・網膜バイオシミラーの南米市場（ブラジル、アルゼンチン） ・網膜バイオシミラーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：黄斑変性症治療薬、糖尿病性眼症治療薬、黄斑斑薬、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Retinal Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Retinal Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Retinal Biosimilars market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Retinal Biosimilars market has been segmented into:
Macular Degeneration Drugs
Diabetic Eye Disease Drugs
Macular Pucker Drugs
Others

By Application, Retinal Biosimilars has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Retinal Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Retinal Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Retinal Biosimilars market.

The report offers in-depth assessment of the growth and other aspects of the Retinal Biosimilars market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Retinal Biosimilars Market Share Analysis
Retinal Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Retinal Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Retinal Biosimilars sales, revenue and market share for each player covered in this report.

The major players covered in Retinal Biosimilars are:
Novartis (Sandoz)
Intas Pharmaceuticals
Genentech
Takeda
Hetero Drugs
Bayer
Regeneron Pharmaceuticals
Reliance Life Sciences
Pfenex
Santo Holding

レポート目次

---

Table of Contents

1 Retinal Biosimilars Market Overview
1.1 Product Overview and Scope of Retinal Biosimilars
1.2 Classification of Retinal Biosimilars by Type
1.2.1 Global Retinal Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Retinal Biosimilars Revenue Market Share by Type in 2019
1.2.3 Macular Degeneration Drugs
1.2.4 Diabetic Eye Disease Drugs
1.2.5 Macular Pucker Drugs
1.2.6 Others
1.3 Global Retinal Biosimilars Market by Application
1.3.1 Overview: Global Retinal Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Retinal Biosimilars Market by Regions
1.4.1 Global Retinal Biosimilars Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Retinal Biosimilars (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Retinal Biosimilars Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Retinal Biosimilars Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Retinal Biosimilars Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Retinal Biosimilars Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Retinal Biosimilars Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis (Sandoz)
2.1.1 Novartis (Sandoz) Details
2.1.2 Novartis (Sandoz) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis (Sandoz) SWOT Analysis
2.1.4 Novartis (Sandoz) Product and Services
2.1.5 Novartis (Sandoz) Retinal Biosimilars Revenue, Gross Margin and Market Share (2018-2019)
2.2 Intas Pharmaceuticals
2.2.1 Intas Pharmaceuticals Details
2.2.2 Intas Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Intas Pharmaceuticals SWOT Analysis
2.2.4 Intas Pharmaceuticals Product and Services
2.2.5 Intas Pharmaceuticals Retinal Biosimilars Revenue, Gross Margin and Market Share (2018-2019)
2.3 Genentech
2.3.1 Genentech Details
2.3.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Genentech SWOT Analysis
2.3.4 Genentech Product and Services
2.3.5 Genentech Retinal Biosimilars Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Retinal Biosimilars Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hetero Drugs
2.5.1 Hetero Drugs Details
2.5.2 Hetero Drugs Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hetero Drugs SWOT Analysis
2.5.4 Hetero Drugs Product and Services
2.5.5 Hetero Drugs Retinal Biosimilars Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer SWOT Analysis
2.6.4 Bayer Product and Services
2.6.5 Bayer Retinal Biosimilars Revenue, Gross Margin and Market Share (2018-2019)
2.7 Regeneron Pharmaceuticals
2.7.1 Regeneron Pharmaceuticals Details
2.7.2 Regeneron Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Regeneron Pharmaceuticals SWOT Analysis
2.7.4 Regeneron Pharmaceuticals Product and Services
2.7.5 Regeneron Pharmaceuticals Retinal Biosimilars Revenue, Gross Margin and Market Share (2018-2019)
2.8 Reliance Life Sciences
2.8.1 Reliance Life Sciences Details
2.8.2 Reliance Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Reliance Life Sciences SWOT Analysis
2.8.4 Reliance Life Sciences Product and Services
2.8.5 Reliance Life Sciences Retinal Biosimilars Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfenex
2.9.1 Pfenex Details
2.9.2 Pfenex Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfenex SWOT Analysis
2.9.4 Pfenex Product and Services
2.9.5 Pfenex Retinal Biosimilars Revenue, Gross Margin and Market Share (2018-2019)
2.10 Santo Holding
2.10.1 Santo Holding Details
2.10.2 Santo Holding Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Santo Holding SWOT Analysis
2.10.4 Santo Holding Product and Services
2.10.5 Santo Holding Retinal Biosimilars Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Retinal Biosimilars Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Retinal Biosimilars Players Market Share
3.2.2 Top 10 Retinal Biosimilars Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Retinal Biosimilars Revenue and Market Share by Regions
4.2 North America Retinal Biosimilars Revenue and Growth Rate (2015-2020)
4.3 Europe Retinal Biosimilars Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Retinal Biosimilars Revenue and Growth Rate (2015-2020)
4.5 South America Retinal Biosimilars Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Retinal Biosimilars Revenue and Growth Rate (2015-2020)
5 North America Retinal Biosimilars Revenue by Countries
5.1 North America Retinal Biosimilars Revenue by Countries (2015-2020)
5.2 USA Retinal Biosimilars Revenue and Growth Rate (2015-2020)
5.3 Canada Retinal Biosimilars Revenue and Growth Rate (2015-2020)
5.4 Mexico Retinal Biosimilars Revenue and Growth Rate (2015-2020)
6 Europe Retinal Biosimilars Revenue by Countries
6.1 Europe Retinal Biosimilars Revenue by Countries (2015-2020)
6.2 Germany Retinal Biosimilars Revenue and Growth Rate (2015-2020)
6.3 UK Retinal Biosimilars Revenue and Growth Rate (2015-2020)
6.4 France Retinal Biosimilars Revenue and Growth Rate (2015-2020)
6.5 Russia Retinal Biosimilars Revenue and Growth Rate (2015-2020)
6.6 Italy Retinal Biosimilars Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Retinal Biosimilars Revenue by Countries
7.1 Asia-Pacific Retinal Biosimilars Revenue by Countries (2015-2020)
7.2 China Retinal Biosimilars Revenue and Growth Rate (2015-2020)
7.3 Japan Retinal Biosimilars Revenue and Growth Rate (2015-2020)
7.4 Korea Retinal Biosimilars Revenue and Growth Rate (2015-2020)
7.5 India Retinal Biosimilars Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Retinal Biosimilars Revenue and Growth Rate (2015-2020)
8 South America Retinal Biosimilars Revenue by Countries
8.1 South America Retinal Biosimilars Revenue by Countries (2015-2020)
8.2 Brazil Retinal Biosimilars Revenue and Growth Rate (2015-2020)
8.3 Argentina Retinal Biosimilars Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Retinal Biosimilars by Countries
9.1 Middle East & Africa Retinal Biosimilars Revenue by Countries (2015-2020)
9.2 Saudi Arabia Retinal Biosimilars Revenue and Growth Rate (2015-2020)
9.3 UAE Retinal Biosimilars Revenue and Growth Rate (2015-2020)
9.4 Egypt Retinal Biosimilars Revenue and Growth Rate (2015-2020)
9.5 South Africa Retinal Biosimilars Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Retinal Biosimilars Revenue and Market Share by Type (2015-2020)
10.2 Global Retinal Biosimilars Market Forecast by Type (2019-2024)
10.3 Macular Degeneration Drugs Revenue Growth Rate (2015-2025)
10.4 Diabetic Eye Disease Drugs Revenue Growth Rate (2015-2025)
10.5 Macular Pucker Drugs Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Retinal Biosimilars Market Segment by Application
11.1 Global Retinal Biosimilars Revenue Market Share by Application (2015-2020)
11.2 Retinal Biosimilars Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Retinal Biosimilars Market Size Forecast (2021-2025)
12.1 Global Retinal Biosimilars Market Size Forecast (2021-2025)
12.2 Global Retinal Biosimilars Market Forecast by Regions (2021-2025)
12.3 North America Retinal Biosimilars Revenue Market Forecast (2021-2025)
12.4 Europe Retinal Biosimilars Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Retinal Biosimilars Revenue Market Forecast (2021-2025)
12.6 South America Retinal Biosimilars Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Retinal Biosimilars Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Retinal Biosimilars Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Retinal Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Retinal Biosimilars Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Retinal Biosimilars Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis (Sandoz) Corporate Information, Location and Competitors
Table 6. Novartis (Sandoz) Retinal Biosimilars Major Business
Table 7. Novartis (Sandoz) Retinal Biosimilars Total Revenue (USD Million) (2017-2018)
Table 8. Novartis (Sandoz) SWOT Analysis
Table 9. Novartis (Sandoz) Retinal Biosimilars Product and Solutions
Table 10. Novartis (Sandoz) Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Intas Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Intas Pharmaceuticals Retinal Biosimilars Major Business
Table 13. Intas Pharmaceuticals Retinal Biosimilars Total Revenue (USD Million) (2018-2019)
Table 14. Intas Pharmaceuticals SWOT Analysis
Table 15. Intas Pharmaceuticals Retinal Biosimilars Product and Solutions
Table 16. Intas Pharmaceuticals Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Genentech Corporate Information, Location and Competitors
Table 18. Genentech Retinal Biosimilars Major Business
Table 19. Genentech Retinal Biosimilars Total Revenue (USD Million) (2017-2018)
Table 20. Genentech SWOT Analysis
Table 21. Genentech Retinal Biosimilars Product and Solutions
Table 22. Genentech Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Takeda Corporate Information, Location and Competitors
Table 24. Takeda Retinal Biosimilars Major Business
Table 25. Takeda Retinal Biosimilars Total Revenue (USD Million) (2017-2018)
Table 26. Takeda SWOT Analysis
Table 27. Takeda Retinal Biosimilars Product and Solutions
Table 28. Takeda Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Hetero Drugs Corporate Information, Location and Competitors
Table 30. Hetero Drugs Retinal Biosimilars Major Business
Table 31. Hetero Drugs Retinal Biosimilars Total Revenue (USD Million) (2017-2018)
Table 32. Hetero Drugs SWOT Analysis
Table 33. Hetero Drugs Retinal Biosimilars Product and Solutions
Table 34. Hetero Drugs Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bayer Corporate Information, Location and Competitors
Table 36. Bayer Retinal Biosimilars Major Business
Table 37. Bayer Retinal Biosimilars Total Revenue (USD Million) (2017-2018)
Table 38. Bayer SWOT Analysis
Table 39. Bayer Retinal Biosimilars Product and Solutions
Table 40. Bayer Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Regeneron Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Regeneron Pharmaceuticals Retinal Biosimilars Major Business
Table 43. Regeneron Pharmaceuticals Retinal Biosimilars Total Revenue (USD Million) (2017-2018)
Table 44. Regeneron Pharmaceuticals SWOT Analysis
Table 45. Regeneron Pharmaceuticals Retinal Biosimilars Product and Solutions
Table 46. Regeneron Pharmaceuticals Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Reliance Life Sciences Corporate Information, Location and Competitors
Table 48. Reliance Life Sciences Retinal Biosimilars Major Business
Table 49. Reliance Life Sciences Retinal Biosimilars Total Revenue (USD Million) (2017-2018)
Table 50. Reliance Life Sciences SWOT Analysis
Table 51. Reliance Life Sciences Retinal Biosimilars Product and Solutions
Table 52. Reliance Life Sciences Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Pfenex Corporate Information, Location and Competitors
Table 54. Pfenex Retinal Biosimilars Major Business
Table 55. Pfenex Retinal Biosimilars Total Revenue (USD Million) (2017-2018)
Table 56. Pfenex SWOT Analysis
Table 57. Pfenex Retinal Biosimilars Product and Solutions
Table 58. Pfenex Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Santo Holding Corporate Information, Location and Competitors
Table 60. Santo Holding Retinal Biosimilars Major Business
Table 61. Santo Holding Retinal Biosimilars Total Revenue (USD Million) (2017-2018)
Table 62. Santo Holding SWOT Analysis
Table 63. Santo Holding Retinal Biosimilars Product and Solutions
Table 64. Santo Holding Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Retinal Biosimilars Revenue (Million USD) by Players (2015-2020)
Table 66. Global Retinal Biosimilars Revenue Share by Players (2015-2020)
Table 67. Global Retinal Biosimilars Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Retinal Biosimilars Revenue Market Share by Regions (2015-2020)
Table 69. North America Retinal Biosimilars Revenue by Countries (2015-2020)
Table 70. North America Retinal Biosimilars Revenue Market Share by Countries (2015-2020)
Table 71. Europe Retinal Biosimilars Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Retinal Biosimilars Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Retinal Biosimilars Revenue by Countries (2015-2020)
Table 74. South America Retinal Biosimilars Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Retinal Biosimilars Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Retinal Biosimilars Revenue Market Share by Countries (2015-2020)
Table 77. Global Retinal Biosimilars Revenue (Million USD) by Type (2015-2020)
Table 78. Global Retinal Biosimilars Revenue Share by Type (2015-2020)
Table 79. Global Retinal Biosimilars Revenue Forecast by Type (2021-2025)
Table 80. Global Retinal Biosimilars Revenue by Application (2015-2020)
Table 81. Global Retinal Biosimilars Revenue Share by Application (2015-2020)
Table 82. Global Retinal Biosimilars Revenue Forecast by Application (2021-2025)
Table 83. Global Retinal Biosimilars Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Retinal Biosimilars Picture
Figure 2. Global Retinal Biosimilars Revenue Market Share by Type in 2019
Figure 3. Macular Degeneration Drugs Picture
Figure 4. Diabetic Eye Disease Drugs Picture
Figure 5. Macular Pucker Drugs Picture
Figure 6. Others Picture
Figure 7. Retinal Biosimilars Revenue Market Share by Application in 2019
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Retinal Biosimilars Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Retinal Biosimilars Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Retinal Biosimilars Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Retinal Biosimilars Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Retinal Biosimilars Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Retinal Biosimilars Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Retinal Biosimilars Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Retinal Biosimilars Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Retinal Biosimilars Revenue Market Share in 2019
Figure 20. Global Top 10 Players Retinal Biosimilars Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Retinal Biosimilars Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Retinal Biosimilars Revenue Market Share by Regions (2015-2020)
Figure 24. Global Retinal Biosimilars Revenue Market Share by Regions in 2018
Figure 25. North America Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 26. Europe Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 28. South America Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 30. North America Retinal Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 31. North America Retinal Biosimilars Revenue Market Share by Countries in 2019
Figure 32. USA Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 33. Canada Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 35. Europe Retinal Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Retinal Biosimilars Revenue Market Share by Countries in 2019
Figure 37. Germany Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 38. UK Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 39. France Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 40. Russia Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 41. Italy Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Retinal Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Retinal Biosimilars Revenue Market Share by Countries in 2019
Figure 44. China Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 45. Japan Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 46. Korea Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 47. India Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 49. South America Retinal Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 50. South America Retinal Biosimilars Revenue Market Share by Countries in 2019
Figure 51. Brazil Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Retinal Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Retinal Biosimilars Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 56. UAE Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Retinal Biosimilars Revenue and Growth Rate (2015-2020)
Figure 59. Global Retinal Biosimilars Revenue Share by Type (2015-2020)
Figure 60. Global Retinal Biosimilars Revenue Share by Type in 2019
Figure 61. Global Retinal Biosimilars Market Share Forecast by Type (2021-2025)
Figure 62. Global Macular Degeneration Drugs Revenue Growth Rate (2015-2020)
Figure 63. Global Diabetic Eye Disease Drugs Revenue Growth Rate (2015-2020)
Figure 64. Global Macular Pucker Drugs Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Retinal Biosimilars Revenue Share by Application (2015-2020)
Figure 67. Global Retinal Biosimilars Revenue Share by Application in 2019
Figure 68. Global Retinal Biosimilars Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 71. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 72. Global Retinal Biosimilars Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Retinal Biosimilars Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Retinal Biosimilars Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Retinal Biosimilars Revenue Market Forecast (2021-2025)
Figure 76. Europe Retinal Biosimilars Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Retinal Biosimilars Revenue Market Forecast (2021-2025)
Figure 78. South America Retinal Biosimilars Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Retinal Biosimilars Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---